215 related articles for article (PubMed ID: 6739312)
1. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
Weber DJ; Tolkoff-Rubin NE; Rubin RH
Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
[TBL] [Abstract][Full Text] [Related]
2. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
Smith BR; LeFrock JL
Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
[TBL] [Abstract][Full Text] [Related]
4. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
Mashimo K
Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
[No Abstract] [Full Text] [Related]
5. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
[TBL] [Abstract][Full Text] [Related]
6. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
Kawamura S; Sugita R; Fujimaki Y; Deguchi K
Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
[TBL] [Abstract][Full Text] [Related]
7. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
9. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
10. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
[TBL] [Abstract][Full Text] [Related]
11. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
Tan TH; Tay L; Yeo M; Feng PH
Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
[No Abstract] [Full Text] [Related]
12. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
[TBL] [Abstract][Full Text] [Related]
13. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Baur C
J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gonorrhea with clavulanate-potentiated amoxicillin (Augmentin).
Munday PE; Bingham JS; Ison CA; Erdman YJ; Harris JR; Easmon CS
Sex Transm Dis; 1985; 12(3):163-5. PubMed ID: 3929409
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagamatsu I; Horiguchi S; Hatae T
Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
[TBL] [Abstract][Full Text] [Related]
17. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
Schaad UB; Casey PA; Cooper DL
Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
[TBL] [Abstract][Full Text] [Related]
19. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
[TBL] [Abstract][Full Text] [Related]
20. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Parker RH; Eggleston M
Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
